Arsenic and gamma-glutamyltransferase increased Patient Reports February 12, 2012

Arsenic Side Effects Report #4940793-8
Arsenic side effect was reported by a Physician from JAPAN on Feb 21, 2006. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Arsenic dosage: 9.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with NAFAMOSTAT MESILATE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5390025-4
Arsenic side effect was reported by a Health Professional from CHINA on June 29, 2007. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic failure, therapeutic agent toxicity. Arsenic dosage: 10MG IN 250ML OF 5% DEXTROSE DAILY INTRAVENOUS DRIP. Patient died.

Arsenic Side Effects Report #5390027-8
Arsenic side effect was reported by a Physician from CHINA on June 29, 2007. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic failure, therapeutic agent toxicity. Arsenic dosage: 10MG IN 250ML OF 5% DEXTROSE DAILY INTRAVENOUS DRIP. Patient died.